General

Showing 1825–1840 of 2270 results

Article: Pirtobrutinib (Jaypirca®) EMA approved for the treatment of patients with relapsed/refractory mantle cell lymphoma who previously received a BTK inhibitor
€3.03 Add to cart
Article: Plasma cell leukaemia with an indolent clinical presentation
€3.03 Add to cart
Article: Platelet Endothelial Aggregation Receptor 1: a novel modifier of neo-angiogenesis
€3.03 Add to cart
Article: PLATELET FUNCTION IN COAGULATION AND THROMBUS FORMATION
€3.03 Add to cart
Article: Platelets contribute to colitis-associated carcinogenesis: evidence from a mouse model
€3.03 Add to cart
Article: Plenary session at ASH 2016
€3.03 Add to cart
Article: Pleuropericardial effusion in CLL patients treated with ibrutinib: a causal relationship?
€3.03 Add to cart
Article: Pneumatic tube transport is feasible for Rotem coagulation tests in a Central laboratory
€3.03 Add to cart
Article: POEMS Syndrome
€3.03 Add to cart
Article: Point of view about new guidelines on ESAs (erythropoiesis-stimulating agents)
€3.03 Add to cart
Article: Polyphosphate, a modulator of hemostasis and thrombosis: a novel target for antithrombotic agents?
€3.03 Add to cart
Article: POMALIDOMIDE ADDED TO BORTEZOMIB AND DEXAMETHASONE DELAYS DISEASE PROGRESSION IN THE SECOND-LINE TREATMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA
€3.03 Add to cart
Article: Pomalidomide: a new hope for relapsed and refractory multiple myeloma
€3.03 Add to cart
Article: PP.01 The role of the de novo DNA methyltransferase DNMT3B in multiple myeloma cell survival and drug resistance
€3.03 Add to cart
Article: PP.02 Mild Cognitive Impairment, Hypoalbuminemia, High Crp And Gi Co-Morbidities: A Frailty Score That Identifies Older Patients With Malignant Hemopathies Who Don’t Benefit From Chemotherapy
€3.03 Add to cart
Article: PP.03 Shallow whole-genome sequencing of cell-free DNA for B-cell lymphoma diagnosis and disease monitoring: a standardized approach with underappreciated potential
€3.03 Add to cart

Article: Pirtobrutinib (Jaypirca®) EMA approved for the treatment of patients with relapsed/refractory mantle cell lymphoma who previously received a BTK inhibitor

Article: Plasma cell leukaemia with an indolent clinical presentation

Article: Platelet Endothelial Aggregation Receptor 1: a novel modifier of neo-angiogenesis

Article: PLATELET FUNCTION IN COAGULATION AND THROMBUS FORMATION

Article: Platelets contribute to colitis-associated carcinogenesis: evidence from a mouse model

Article: Plenary session at ASH 2016

Article: Pleuropericardial effusion in CLL patients treated with ibrutinib: a causal relationship?

Article: Pneumatic tube transport is feasible for Rotem coagulation tests in a Central laboratory

Article: POEMS Syndrome

Article: Point of view about new guidelines on ESAs (erythropoiesis-stimulating agents)

Article: Polyphosphate, a modulator of hemostasis and thrombosis: a novel target for antithrombotic agents?

Article: POMALIDOMIDE ADDED TO BORTEZOMIB AND DEXAMETHASONE DELAYS DISEASE PROGRESSION IN THE SECOND-LINE TREATMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA

Article: Pomalidomide: a new hope for relapsed and refractory multiple myeloma

Article: PP.01 The role of the de novo DNA methyltransferase DNMT3B in multiple myeloma cell survival and drug resistance

Article: PP.02 Mild Cognitive Impairment, Hypoalbuminemia, High Crp And Gi Co-Morbidities: A Frailty Score That Identifies Older Patients With Malignant Hemopathies Who Don’t Benefit From Chemotherapy

Article: PP.03 Shallow whole-genome sequencing of cell-free DNA for B-cell lymphoma diagnosis and disease monitoring: a standardized approach with underappreciated potential